Theodore Ng has experience spanning biomedical research, biotechnology investment, and strategic advisory across the Asia-Pacific region. Following doctoral and postdoctoral training in cardiovascular and metabolic disease research, he transitioned into biotechnology consulting, advising investment groups on emerging therapies and translational innovation in the life sciences sector.
His background brings together scientific and commercial perspectives, informed by experience in securing competitive research funding and by advisory work with private sector investment groups. He remains engaged in research capability development at the Harry Perkins Institute of Medical Research and contributes to strategic engagement supporting Perth’s biotechnology growth.
